• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经结节病的治疗:临床挑战。

Management of neurosarcoidosis: a clinical challenge.

机构信息

ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein.

Department of Pulmonology, Division of Heart & Lungs, University Medical Centre Utrecht, Utrecht.

出版信息

Curr Opin Neurol. 2019 Jun;32(3):475-483. doi: 10.1097/WCO.0000000000000684.

DOI:10.1097/WCO.0000000000000684
PMID:30865007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6522203/
Abstract

PURPOSE OF REVIEW

Sarcoidosis is a complex disease with many faces, and the clinical manifestation and course of neurosarcoidosis are particularly variable. Although neurosarcoidosis occurs in up to 10% of sarcoidosis patients, it can lead to significant morbidity and some mortality.

RECENT FINDINGS

Three criteria are usually required for a diagnosis of (neuro)sarcoidosis: clinical and radiologic manifestations, noncaseating granulomas, and no evidence of alternative disease. Recent guidelines have helped to clarify criteria for diagnosing neurosarcoidosis. No firm guidelines exist on whether, when, and how treatment should be started. Treatment depends on the presentation and distribution, extensiveness, and severity of neurosarcoidosis. As regards evidence-based treatment, only a few randomized controlled trials have been done. Hence, several aspects of (neuro)sarcoidosis management are not fully addressed by the current literature.

SUMMARY

Significant advances have been made in the potential and accuracy of diagnostics for neurosarcoidosis. Treatment should be approached within the context of the patient's anticipated clinical course, avoidance of adverse drug effects, and, if necessary, from the perspective of the comprehensive management of a chronic disease. A multidisciplinary approach to the management of sarcoidosis is strongly recommended.

摘要

目的综述

结节病是一种具有多种表现的复杂疾病,神经结节病的临床表现和病程尤其多变。尽管神经结节病可发生于高达 10%的结节病患者中,但它可导致显著的发病率和一些死亡率。

最近的发现

(神经)结节病的诊断通常需要符合以下三个标准:临床表现和影像学表现、非干酪样肉芽肿以及无其他疾病的证据。最近的指南有助于阐明神经结节病的诊断标准。关于何时以及如何开始治疗尚无明确的准则。治疗取决于神经结节病的表现、分布、广泛程度和严重程度。关于基于证据的治疗,仅进行了少数随机对照试验。因此,目前的文献并没有完全解决(神经)结节病管理的几个方面。

总结

在神经结节病的诊断潜力和准确性方面已经取得了重大进展。治疗应根据患者预期的临床病程、避免药物不良反应以及必要时从慢性病的综合管理角度来进行。强烈建议采用多学科方法来管理结节病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/f056fd89f5d2/coneu-32-475-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/4f7612ca4ba2/coneu-32-475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/a37176f57cfd/coneu-32-475-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/50ef79c65bbc/coneu-32-475-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/f056fd89f5d2/coneu-32-475-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/4f7612ca4ba2/coneu-32-475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/a37176f57cfd/coneu-32-475-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/50ef79c65bbc/coneu-32-475-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a62/6522203/f056fd89f5d2/coneu-32-475-g004.jpg

相似文献

1
Management of neurosarcoidosis: a clinical challenge.神经结节病的治疗:临床挑战。
Curr Opin Neurol. 2019 Jun;32(3):475-483. doi: 10.1097/WCO.0000000000000684.
2
Diagnosis and management of neurosarcoidosis.神经结节病的诊断与管理
J Clin Neurosci. 2001 Nov;8(6):505-13. doi: 10.1054/jocn.2000.0950.
3
Neurosarcoidosis.神经结节病
Continuum (Minneap Minn). 2014 Jun;20(3 Neurology of Systemic Disease):545-59. doi: 10.1212/01.CON.0000450965.30710.e9.
4
Neurosarcoidosis.神经结节病
Rheum Dis Clin North Am. 2017 Nov;43(4):593-606. doi: 10.1016/j.rdc.2017.06.008. Epub 2017 Aug 23.
5
[Neurosarcoidosis: Diagnosis and therapeutic issues].[神经结节病:诊断与治疗问题]
Rev Med Interne. 2017 Jun;38(6):393-401. doi: 10.1016/j.revmed.2016.10.392. Epub 2016 Nov 21.
6
Many faces of neurosarcoidosis: from chronic meningitis to myelopathy.神经结节病的多种表现:从慢性脑膜炎到脊髓病。
Curr Opin Pulm Med. 2017 Sep;23(5):439-446. doi: 10.1097/MCP.0000000000000401.
7
Neurosarcoidosis: a clinical approach to diagnosis and management.神经结节病:诊断与管理的临床方法
J Neurol. 2017 May;264(5):1023-1028. doi: 10.1007/s00415-016-8336-4. Epub 2016 Nov 22.
8
Neurosarcoidosis.神经结节病
Semin Respir Crit Care Med. 2017 Aug;38(4):499-513. doi: 10.1055/s-0037-1604165. Epub 2017 Jul 27.
9
Neurosarcoidosis: clinical characteristics, diagnosis, and treatment in eight Chinese patients.神经结节病:8 例中国患者的临床特征、诊断和治疗。
Neurol Sci. 2018 Oct;39(10):1725-1733. doi: 10.1007/s10072-018-3491-2. Epub 2018 Aug 7.
10
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.神经结节病伪装成多发性硬化症:诊断过程中的考验与磨难。
Mult Scler Relat Disord. 2015 Sep;4(5):414-429. doi: 10.1016/j.msard.2015.06.012. Epub 2015 Jun 24.

引用本文的文献

1
Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United States.结节病性神经病变管理的共识性建议:一项针对美国各地专家的德尔菲调查
Neurol Clin Pract. 2025 Apr;15(2):e200429. doi: 10.1212/CPJ.0000000000200429. Epub 2025 Jan 15.
2
The pleomorphic phenotype of neurosarcoidosis.神经结节病的多形性表型。
Neurol Sci. 2025 Apr;46(4):1945-1947. doi: 10.1007/s10072-024-07914-w. Epub 2024 Dec 20.
3
Neurosarcoidosis: Current Perspectives on Diagnosis, Management, and Future Directions.

本文引用的文献

1
Everyday cognitive failure in patients suffering from neurosarcoidosis.神经结节病患者的日常认知功能衰退
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):2-10. doi: 10.36141/svdld.v36i1.7412. Epub 2019 May 1.
2
Cardiac sarcoidosis: Diagnosis confirmation by bronchoalveolar lavage and lung biopsy.心脏结节病:支气管肺泡灌洗和肺活检的诊断确认。
Respir Med. 2018 Nov;144S:S13-S19. doi: 10.1016/j.rmed.2018.09.008. Epub 2018 Sep 16.
3
Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.
神经结节病:关于诊断、管理及未来方向的当前观点
Cureus. 2024 Sep 11;16(9):e69208. doi: 10.7759/cureus.69208. eCollection 2024 Sep.
4
Longitudinally extensive transverse myelitis as an initial manifestation of sarcoidosis: A rare case and its management.结节病的初始表现为纵向广泛横贯性脊髓炎:1例罕见病例及其处理
Clin Case Rep. 2024 Jul 7;12(7):e9135. doi: 10.1002/ccr3.9135. eCollection 2024 Jul.
5
Neurosarcoidosis: An under-diagnosed cause of myelopathy.神经结节病:脊髓病的一种诊断不足的病因。
J Family Med Prim Care. 2024 May;13(5):2157-2160. doi: 10.4103/jfmpc.jfmpc_987_23. Epub 2024 May 24.
6
Diagnostic challenges of neurosarcoidosis in non-endemic areas.非流行地区神经结节病的诊断挑战
Front Neurol. 2024 Jan 11;14:1220635. doi: 10.3389/fneur.2023.1220635. eCollection 2023.
7
Reevaluating the relevance of F-FDG PET findings for diagnosis of neurosarcoidosis: a case series.重新评估F-FDG PET检查结果对神经结节病诊断的相关性:病例系列研究
Neurol Res Pract. 2024 Jan 25;6(1):12. doi: 10.1186/s42466-023-00299-9.
8
Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation.神经结节病性心脏病:一项单中心研究。
Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200196. doi: 10.1212/NXI.0000000000200196. Epub 2024 Jan 5.
9
A rare case of sarcoid myelitis complicating Löfgren's syndrome.1例罕见的结节病性脊髓炎合并Löfgren综合征。
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023052. doi: 10.36141/svdld.v40i4.13104.
10
Typical trident sign and cardiac involvement in a patient suspected to Sarcoidosis despite negative whole-body FDG-PET: a case report.疑似结节病患者出现典型三叉戟征和心脏受累,尽管全身 FDG-PET 检查为阴性:病例报告。
J Med Case Rep. 2023 Nov 30;17(1):496. doi: 10.1186/s13256-023-04224-1.
神经结节病的定义和共识诊断标准:来自神经结节病共识组。
JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295.
4
PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations.PET/CT 在结节病的诊断和研究中的应用:关注不典型表现。
Radiographics. 2018 Sep-Oct;38(5):1536-1549. doi: 10.1148/rg.2018180053. Epub 2018 Aug 17.
5
Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.结节病的需求、认知和教育:对患者和其伴侣的实时互动调查。
Lung. 2018 Oct;196(5):569-575. doi: 10.1007/s00408-018-0144-4. Epub 2018 Aug 7.
6
Sarcoidosis from Head to Toe: What the Radiologist Needs to Know.从头至脚的结节病:放射科医生需要了解的知识。
Radiographics. 2018 Jul-Aug;38(4):1180-1200. doi: 10.1148/rg.2018170157.
7
Treatment of sarcoidosis: grading the evidence.结节病的治疗:证据分级。
Expert Rev Clin Pharmacol. 2018 Jul;11(7):677-687. doi: 10.1080/17512433.2018.1486706. Epub 2018 Jun 18.
8
Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.结节病诊断评分:一项系统性评估以提高结节病的诊断。
Chest. 2018 Nov;154(5):1052-1060. doi: 10.1016/j.chest.2018.05.003. Epub 2018 May 17.
9
Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy.角膜神经纤维大小有助于诊断和评估小纤维神经病患者的治疗反应。
Sci Rep. 2018 Mar 16;8(1):4734. doi: 10.1038/s41598-018-23107-w.
10
Efficacy and safety of infliximab biosimilar Inflectra in severe sarcoidosis.英夫利昔单抗生物类似药Inflectra治疗重度结节病的疗效与安全性
Respir Med. 2018 May;138S:S7-S13. doi: 10.1016/j.rmed.2018.02.009. Epub 2018 Feb 19.